The single cell analysis market is expected to grow globally at a CAGR of 16.79% between the forecast periods of 2018-2026. The key market drivers for this expected growth is the increased technological advancement in single cell analysis products in recent years, the increasing number of biopharmaceutical and biotechnological companies, and the increasing prevalence of chronic infectious diseases globally.
The single cell analysis market is mainly divided on the basis of segments like applications, techniques, cell-types, products and end-users. The application segment further involves research application and medical application. The research applications consist of various sub-segments such as cancer market, immunology market, neurology market, and the stem cells market along with various other research application of single cell analysis.In terms of techniques, microscopy is currently the fastest growing market with an expected CAGR of xx%. With respect to the cell type, the human cells market presently holds the largest market share in the global single cell analysis market. Also, the consumables products are fast becoming current market leaders, while the end-user segment of this market can be classified into Biopharmaceutical and biotechnology companies, cell banks and IVF centers, hospitals and diagnostics laboratories and research & academic laboratories.
The increasing applications of single-cell analysis in cancer research in North America due to advanced technology, booming biotechnology and biopharmaceutical industries and the rising prevalence of infectious diseases, is estimated to fetch the region with the highest share of the global single cell market by the year 2026. This is closely followed by Europe and the Asia-Pacific. In fact, the Asia-Pacific market is anticipated to grow considerably fast over the forecast period owing to the rising need for stem cell therapies and an increasing prevalence of lifestyle-oriented diseases in the region.
The major companies competing in the single cell analysis market are Beckton Dickinson, Miltenyi Biotec, Corning Inc, Nanostring technologies Inc, Celgene Corporation, Agilent technology Inc, Medtronic’s, Qiagen, GE Healthcare, Beckman Coulter Inc, Leica, Merck Kgaa, Stem Cell Technologies and Thermo Fisher.